English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > がん > 欧州の癌市場における問題、動向および罹患率
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

欧州の癌市場における問題、動向および罹患率

Issues; Trends and Prevalence in the European Cancer Therapy Market- Non Pharmaceutical

発行 Frost & Sullivan
出版日 2008年10月 商品コード 75567
ページ情報 英文 160 Pages
価格
US$ 6,500 換算 ¥ 523,055 (税抜) Web Access (Regional License)
US$ 7,000 換算 ¥ 563,290 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research service examines the Issues, trends and prevalence in the European cancer therapy market in terms of the challenges faced by market participants, drivers, and restraints in the industry, the competitive structure in the major markets as well as the upcoming technologies.

Table of Contents

1. EXECUTIVE SUMMARY

  • Summary of Major Findings
    • 1. Executive Summary

2. RESEARCH SCOPE AND METHODOLOGY

  • Scope and Methodology
    • 1. Scope and Methodology

3. INTRODUCTION

  • Introduction
    • 1. Research Study Overview
    • 2. Cancer

4. TYPES OF CANCER

  • Introduction
    • 1. Introduction to Types of Cancers
  • Breast Cancer
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Lung Cancer
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Colon Cancer
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Prostate Cancer
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Leukemia
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Lymphoma
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Uterine Cancer
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence

5. MARKET OUTLOOK

  • Introduction
    • 1. Radiotherapy Devices
  • Industry Challenges
    • 1. Challenges in the European Market
  • Drivers and Restraints
    • 1. Drivers
    • 2. Restraints
  • Key Market Participants and Products Available
    • 1. Key Market Participants
    • 2. Key Products
  • Country Profile
    • 1. Germany
    • 2. France
    • 3. Italy
    • 4. Spain
    • 5. United Kingdom
    • 6. Benelux
    • 7. Scandinavia
  • Radiotherapy Resources
    • 1. Radiotherapy Resources in Europe
  • Treatment Distribution
    • 1. Treatment Distribution in Europe

6. THINKING OUTSIDE THE BOX

  • Competitive Structure and Opportunities
    • 1. Competitive Structure
    • 2. Opportunities
  • Future Outlook
    • 1. A Future Outlook for the European Industry
  • Conclusion
    • 1. Radiotherapy Devices- Conclusion

7. DECISION SUPPORT DATABASE

  • Database
    • 1. Number of Hospitals- Western Europe
    • 2. Private Healthcare Expenditure
    • 3. Government Healthcare Expenditure
    • 4. Population Aged 65 and above
    • 5. Per Capita Healthcare Expenditure
Back to Top